Incidence and risk factors of posttraumatic hydrocephalus and its association with outcome following intensive care unit treatment for traumatic brain injury: a multicenter observational study.


Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
01 11 2023
Historique:
received: 27 03 2022
accepted: 21 02 2023
medline: 3 11 2023
pubmed: 9 4 2023
entrez: 8 4 2023
Statut: epublish

Résumé

Posttraumatic hydrocephalus (PTH) is a recognized long-term complication of traumatic brain injury (TBI). The authors assessed the incidence and risk factors of PTH and its association with outcome in patients with TBI who were treated in the intensive care unit (ICU). The authors used the Finnish Intensive Care Consortium (FICC) database to retrospectively identify all adult patients with TBI treated in 4 Finnish tertiary ICUs during 2003-2013. All patients were followed up from hospital discharge to a diagnosis of PTH, death, or the end of 2016. PTH was defined as a need for a postdischarge ventriculoperitoneal or ventriculoatrial shunt. The authors collected data on shunt-insertion procedures, mortality, and disability status from nationwide registries cross-linked to the FICC database. The authors calculated the occurrence and incidence rates of PTH and used multivariable logistic regression modeling to determine risk factors for PTH and its association with outcome. Sixty-one of 2882 patients (2.1%) developed PTH during a median follow-up time of 4.6 years, with a median of 102 days (interquartile range 54-220 days) between hospital discharge and PTH. Risk factors for PTH were increasing age (OR 1.02 per year, 95% CI 1.01-1.04); a midline shift of > 5 mm (OR 1.88, 95% CI 1.01-3.48); traumatic subarachnoid hemorrhage (OR 3.59, 95% CI 1.79-7.21); external ventricular drainage (OR 3.54, 95% CI 1.68-7.46); and decompressive craniectomy (OR 3.68, 95% CI 1.37-9.88). PTH was independently associated with permanent disability after case-mix adjustment (OR 3.62, 95% CI 2.11-6.22). PTH is an uncommon long-term complication of TBI, with several risk factors that are identifiable early during neurointensive care. The development of PTH is independently associated with poor functional outcome. Whether earlier detection and treatment of PTH leads to improved outcomes remains unknown, highlighting the importance of adequate follow-up and prompt detection and treatment of the condition.

Identifiants

pubmed: 37029677
doi: 10.3171/2023.2.JNS22728
doi:

Types de publication

Multicenter Study Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1420-1429

Auteurs

Matias Lindfors (M)

1Department of Neurosurgery, University of Helsinki and Helsinki University Hospital, Helsinki.

Juho Vehviläinen (J)

1Department of Neurosurgery, University of Helsinki and Helsinki University Hospital, Helsinki.

Stepani Bendel (S)

3Department of Anesthesiology and Intensive Care, Kuopio University Hospital and University of Eastern Finland, Kuopio.

Matti Reinikainen (M)

3Department of Anesthesiology and Intensive Care, Kuopio University Hospital and University of Eastern Finland, Kuopio.

Ruut Laitio (R)

4Department of Intensive Care, Turku University Hospital and University of Turku.

Tero Ala-Kokko (T)

5Department of Intensive Care, Oulu University Hospital and University of Oulu, Medical Research Center, Research Group of Surgery, Anesthesiology and Intensive Care, Oulu; and.

Sanna Hoppu (S)

6Department of Intensive Care and Emergency Medical Services, Tampere University Hospital and University of Tampere, Finland.

Jari Siironen (J)

1Department of Neurosurgery, University of Helsinki and Helsinki University Hospital, Helsinki.

Markus B Skrifvars (MB)

2Division of Intensive Care, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki.

Rahul Raj (R)

1Department of Neurosurgery, University of Helsinki and Helsinki University Hospital, Helsinki.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH